Related content

Pharmacology and Therapeutics of Gabapentin in the Treatment of Psychiatric Disorders; Present and Future Perspectives

By  

Current Neuropharmacology, Vol. 1, Iss. 3, 2003-09 ,pp. : 187-197

Bentham Science Publishers

Access to resources Recommend Favorite

The future of psychiatric pharmacogenomics

By Lohoff Falk W  

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 927-929

Future Medicine

Access to resources Recommend Favorite

Genomic Signatures for Individualized Treatment of Malignant Tumors

By  

Current Drug Discovery Technologies, Vol. 5, Iss. 1, 2008-03 ,pp. : 9-14

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics for the Individualization of Psychiatric Treatment

By Arranz M.J.   Collier D.   Kerwin R.W.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 1, 2001-01 ,pp. : 3-10

Adis International

Access to resources Recommend Favorite

Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment

By Ingelman-Sundberg M.   Oscarson M.   McLellan R.A.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 8, 1999-08 ,pp. : 342-349

Elsevier

Access to resources Recommend Favorite